Reuters logo
BRIEF-PhaseRx receives Orphan Drug Designation from FDA for PRX-ASL
2017年9月20日 / 晚上7点47分 / 1 个月内

BRIEF-PhaseRx receives Orphan Drug Designation from FDA for PRX-ASL

Sept 20 (Reuters) - PhaseRx Inc:

* PhaseRx receives Orphan Drug Designation from FDA for PRX-ASL for the treatment of Argininosuccinate Lyase Deficiency Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below